Sorich J - Search Results

1

Phase I study of combined pegylated liposomal doxorubicin with protracted daily topotecan for ovarian cancer.

Mirchandani D, Hochster H, Hamilton A, Liebes L, Yee H, Curtin JP, Lee S, Sorich J, Dellenbaugh C, Muggia FM. Mirchandani D, et al. Among authors: sorich j. Clin Cancer Res. 2005 Aug 15;11(16):5912-9. doi: 10.1158/1078-0432.CCR-04-1240. Clin Cancer Res. 2005. PMID: 16115933 Clinical Trial.

2

Phase I and pharmacologic study of i.p. 9-aminocamptothecin given as six fractions over 14 days.

Muggia FM, Liebes L, Hazarika M, Wadler S, Hamilton A, Hornreich G, Sorich J, Chiang C, Newman E, Potmesil M, Hochster H. Muggia FM, et al. Among authors: sorich j. Anticancer Drugs. 2002 Sep;13(8):819-25. doi: 10.1097/00001813-200209000-00006. Anticancer Drugs. 2002. PMID: 12394266 Clinical Trial.

3

Biweekly 72-hour 9-aminocamptothecin infusion as second-line therapy for ovarian carcinoma: phase II study of the New York Gynecologic Oncology Group and the Eastern Cooperative Oncology Group.

Hochster H, Plimack ER, Runowicz CD, Speyer J, Wallach RC, Sorich J, Mandeli J, Wadler S, Wright J, Muggia FM. Hochster H, et al. Among authors: sorich j. J Clin Oncol. 2004 Jan 1;22(1):120-6. doi: 10.1200/JCO.2004.03.016. J Clin Oncol. 2004. PMID: 14701774 Clinical Trial.

4

A phase I and pharmacokinetic study of docetaxel combined with Doxil (pegylated liposomal doxorubicin) without and with granulocyte colony stimulating factor.

Pavlick AC, Chodkiewicz C, Liebes L, Hamilton A, Wasserheit C, Hochster H, Speyer J, Phillips Z, Downey A, Sorich J, Muggia F. Pavlick AC, et al. Among authors: sorich j. Anticancer Drugs. 2004 Feb;15(2):119-25. doi: 10.1097/00001813-200402000-00004. Anticancer Drugs. 2004. PMID: 15075667 Clinical Trial.

5

Tolerance and activity of oxaliplatin with protracted topotecan infusion in patients with previously treated ovarian cancer. A phase I study.

Hochster H, Chen TT, Lu JM, Hills D, Sorich J, Escalon J, Ivy P, Liebes L, Muggia F. Hochster H, et al. Among authors: sorich j. Gynecol Oncol. 2008 Mar;108(3):500-4. doi: 10.1016/j.ygyno.2007.11.017. Epub 2008 Jan 11. Gynecol Oncol. 2008. PMID: 18191187 Free PMC article. Clinical Trial.

6

Phase I trial of low-dose continuous topotecan infusion in patients with cancer: an active and well-tolerated regimen.

Hochster H, Liebes L, Speyer J, Sorich J, Taubes B, Oratz R, Wernz J, Chachoua A, Raphael B, Vinci RZ, et al. Hochster H, et al. Among authors: sorich j. J Clin Oncol. 1994 Mar;12(3):553-9. doi: 10.1200/JCO.1994.12.3.553. J Clin Oncol. 1994. PMID: 8120553 Clinical Trial.

7

Effect of prolonged topotecan infusion on topoisomerase 1 levels: a phase I and pharmacodynamic study.

Hochster H, Liebes L, Speyer J, Sorich J, Taubes B, Oratz R, Wernz J, Chachoua A, Blum RH, Zeleniuch-Jacquotte A. Hochster H, et al. Among authors: sorich j. Clin Cancer Res. 1997 Aug;3(8):1245-52. Clin Cancer Res. 1997. PMID: 9815806 Clinical Trial.

8

Activity and pharmacodynamics of 21-Day topotecan infusion in patients with ovarian cancer previously treated with platinum-based chemotherapy. New York Gynecologic Oncology Group.

Hochster H, Wadler S, Runowicz C, Liebes L, Cohen H, Wallach R, Sorich J, Taubes B, Speyer J. Hochster H, et al. Among authors: sorich j. J Clin Oncol. 1999 Aug;17(8):2553-61. doi: 10.1200/JCO.1999.17.8.2553. J Clin Oncol. 1999. PMID: 10561322 Clinical Trial.

9

Neoadjuvant chemotherapy with CPT-11 and cisplatin downstages locally advanced gastric cancer.

Newman E, Marcus SG, Potmesil M, Sewak S, Yee H, Sorich J, Hayek M, Muggia F, Hochster H. Newman E, et al. Among authors: sorich j. J Gastrointest Surg. 2002 Mar-Apr;6(2):212-23; discussion 223. doi: 10.1016/s1091-255x(01)00054-3. J Gastrointest Surg. 2002. PMID: 11992807 Clinical Trial.

10

A phase I study of paclitaxel, estramustine phosphate and vinorelbine (Pacl-E-Vin) in advanced malignancies: triple tubulin targeting.

Sewak S, Chachoua A, Hamilton A, Taneja S, Lee J, Utate M, Sorich J, Muggia FM. Sewak S, et al. Among authors: sorich j. Anticancer Drugs. 2003 Jan;14(1):67-72. doi: 10.1097/00001813-200301000-00009. Anticancer Drugs. 2003. PMID: 12544260 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters